Summary

Active Pharmaceutical ingredient Market Size, Share, and Analysis, By Type (Innovative API and Generic API), By Manufacturer (Captive API Manufacturer and Merchant API Manufacturer), By Synthesis (Synthetic APIs and Biotech APIs), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Urology, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

PRODUCT OVERVIEW
Active Pharmaceutical ingredient Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 6% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 239.2 billion and is projected to reach USD 453.3 billion by the completion of 2034.
Active Pharmaceutical Ingredient (API) is the component in a pharmaceutical drug that produces the intended therapeutic effects. It is the primary element responsible for the drug’s action in treating, preventing, or diagnosing a disease. APIs are made using chemical methods, biotechnological techniques, or by extracting them from natural sources. The quality and purity of APIs are crucial as they directly impact the drug's efficacy and safety. However, the production of APIs involves stringent regulations and quality control measures to ensure consistency and compliance with standards set by regulatory bodies like the FDA or EMA. In a medication, the API is often combined with excipients, which are inactive substances that help the drug be delivered and absorbed in the body.

MARKET HIGHLIGHTS
Active Pharmaceutical ingredient Market is expected to reach USD 453.3 billion during the forecast period, as the market encompasses the production and distribution of the biologically active components in medications. It is a crucial sector within the pharmaceutical industry, driving innovation and growth. The market's dynamics are influenced by factors such as technological advancements in API synthesis, regulatory changes, and the increasing demand for generic drugs worldwide. Key players in the API market include manufacturers, suppliers, and contract research organizations (CROs) involved in API development and production. However, the market is known for its strict quality standards and regulatory requirements, which are essential to guarantee the safety and effectiveness of medications. As global healthcare demands change, driven by aging populations and increasing chronic illnesses, the API market is growing. This growth is fueled by continuous research and development aimed at creating newer and more efficient therapeutic substances.
Active Pharmaceutical ingredient Market Segments:

• By Type
o Innovative API
o Generic API
o By Manufacturer
o Captive API Manufacturer
o Merchant API Manufacturer
• By Synthesis
o Synthetic APIs
o Biotech APIs Others
• By Application
o Cardiovascular Disease
o Oncology
o Neurological Disorders
o Orthopedic Disorders
o Respiratory
o Urology
o Others


MARKET DYNAMICS
Growth Drivers
Increasing Demand for Generic Drugs is Expected to Foster Market Expansion
Technological Advancements in API Production are anticipated to drive market growth
Restraint
High Cost of R&D and Manufacturing Can Limit the Growth of the Active Pharmaceutical ingredient Market

Key Players
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Novartis International AG
• Sanofi S.A.
• Boehringer Ingelheim International GmbH
• GlaxoSmithKline plc
• Merck & Co., Inc.
• AstraZeneca plc
• Eli Lilly and Company
• AbbVie Inc.
• Cipla Inc.
• Sun Pharmaceutical Industries Ltd.
• Aurobindo Pharma Ltd.
• Dr. Reddy's Laboratories Ltd.
• Lonza Group AG
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)


Global Laboratory Temperature Control Units Market is further segmented by region into:
• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA


Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 3-month post-sales analyst support.

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3.Global Active Pharmaceutical ingredient Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Global Active Pharmaceutical ingredient Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Global Active Pharmaceutical ingredient Market – Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porter's Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Global Active Pharmaceutical ingredient Market
10.1.Overview
10.2. Historical Analysis (2018-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Global Active Pharmaceutical ingredient Market Size & Forecast 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Type
11.3.1.1. Innovation API
11.3.1.1.1. By Value (USD Million) 2024A-2034F
11.3.1.1.2.Market Share (%) 2024A-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024A-2034F
11.3.1.2.Generic API
11.3.1.2.1.By Value (USD Million) 2024A-2034F
11.3.1.2.2. Market Share (%) 2024A-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.3.Others
11.3.1.3.1.By Value (USD Million) 2024A-2034F
11.3.1.3.2. Market Share (%) 2024A-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2. By Manufacturer
11.3.2.1.Captive API Manufacturer
11.3.2.1.1.By Value (USD Million) 2024A-2034F
11.3.2.1.2. Market Share (%) 2024A-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2.2. Merchant API Manufacturer
11.3.2.2.1. By Value (USD Million) 2024A-2034F
11.3.2.2.2.Market Share (%) 2024A-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2024A-2034F
11.3.2.3.2.Market Share (%) 2024A-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024A-2034F
11.3.3. By Synthesis
11.3.3.1.Synthetic APIs
11.3.3.1.1.By Value (USD Million) 2024A-2034F
11.3.3.1.2. Market Share (%) 2024A-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.3.2. Biotech APIs
11.3.3.2.1. By Value (USD Million) 2024A-2034F
11.3.3.2.2.Market Share (%) 2024A-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.4. Application
11.3.4.1.Cardiovascular Disease
11.3.4.1.1.By Value (USD Million) 2024A-2034F
11.3.4.1.2. Market Share (%) 2024A-2034F
11.3.4.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.4.2. Oncology
11.3.4.2.1. By Value (USD Million) 2024A-2034F
11.3.4.2.2.Market Share (%) 2024A-2034F
11.3.4.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.4.3. Neurological Disorders
11.3.4.3.1. By Value (USD Million) 2024A-2034F
11.3.4.3.2. Market Share (%) 2024A-2034F
11.3.4.3.3. Y-o-Y Growth (%) 2024A-2034F
11.3.4.4. Orthopedic Disorders
11.3.4.4.1.By Value (USD Million) 2024A-2034F
11.3.4.4.2. Market Share (%) 2024A-2034F
11.3.4.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.4.5. Respiratory
11.3.4.5.1.By Value (USD Million) 2024A-2034F
11.3.4.5.2. Market Share (%) 2024A-2034F
11.3.4.5.3. Y-o-Y Growth (%) 2024A-2034F
11.3.4.6. Urology
11.3.4.6.1. By Value (USD Million) 2024A-2034F
11.3.4.6.2.Market Share (%) 2024A-2034F
11.3.4.6.3.Y-o-Y Growth (%) 2024A-2034F
11.3.4.7. Others
11.3.4.7.1. By Value (USD Million) 2024A-2034F
11.3.4.7.2.Market Share (%) 2024A-2034F
11.3.4.7.3.Y-o-Y Growth (%) 2024A-2034F
12. North America Active Pharmaceutical ingredient Market Size & Forecast 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Type
12.3.2.By Manufacturer
12.3.3.By Synthesis
12.3.4.By Application
12.4. Country
12.4.1. United States
12.4.2.Canada
13. Europe Active Pharmaceutical ingredient Market Size & Forecast 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Type
13.3.2.By Manufacturer
13.3.3.By Synthesis
13.3.4.By Application
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia-Pacific Active Pharmaceutical ingredient Market Size & Forecast 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Type
14.3.2.By Manufacturer
14.3.3.By Synthesis
14.3.4. By Application
14.4. Country
14.4.1.India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Active Pharmaceutical ingredient Market Size & Forecast 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Type
15.3.2.By Manufacturer
15.3.3.By Synthesis
15.3.4.By Application
15.4. Country
15.4.1.Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa
16. Latin America Active Pharmaceutical ingredient Market Size & Forecast 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Type
16.3.2.By Manufacturer
16.3.3.By Synthesis
16.3.4.By Application
16.4. Country
16.4.1.Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1.Teva Pharmaceutical Industries Ltd.
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2.Key Clients
18.1.4.3.Market Share
18.1.4.4.Recent News & Development (Last 3 Yrs.)
18.2. Pfizer Inc.
18.3. Novartis International AG
18.4. Sanofi S.A.
18.5. Boehringer Ingelheim International GmbH
18.6. GlaxoSmithKline plc
18.7. Merck & Co., Inc.
18.8. AstraZeneca plc
18.9. Eli Lilly and Company
18.10. AbbVie Inc.
18.11.Cipla Inc.
18.12. Sun Pharmaceutical Industries Ltd.
18.13. Aurobindo Pharma Ltd.
18.14. Dr. Reddy's Laboratories Ltd.
18.15. Lonza Group AG
18.16. Other Prominent Players
19. Appendix
20.Consultant Recommendation